What is Nidan Laboratories And Healthcare share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Nidan Laboratories And Healthcare?

The latest standalone P/E ratio of Nidan Laboratories And Healthcare as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Nidan Laboratories And Healthcare?

The latest standalone P/B ratio of Nidan Laboratories And Healthcare as of 01-Jan-1970 is 0.60.

What is the 52-week high and low of Nidan Laboratories And Healthcare?

The 52-week high of Nidan Laboratories And Healthcare is Rs. 0.00 and the 52-week low is Rs. 0.00.

What is the TTM revenue of Nidan Laboratories And Healthcare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Laboratories And Healthcare is Rs. 24.18 (Cr.).

Nidan Laboratories And Healthcare Ltd - Stock Valuation and Financial Performance

Name: Nidan Laboratories And Healthcare
Brand: Nidan Laboratories And Healthcare

BSE: 0 | NSE: NIDAN | Hospital & Healthcare Services | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Nidan Labs. & Health

Based on:

Data

M-Cap below 100cr DeciZen not available

Nidan Laboratories And Healthcare stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

40 Cr.

52-wk low:

52-wk high:

Is Nidan Laboratories And Healthcare Ltd an attractive stock to invest in?

1. Is Nidan Laboratories And Healthcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nidan Laboratories And Healthcare Ltd is a average quality company.

2. Is Nidan Laboratories And Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Nidan Laboratories And Healthcare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Nidan Laboratories And Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nidan Laboratories And Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Nidan Labs. & Health:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	11.7%	10.2%	14%	10.5%	8.5%	-0.2%	-
Value Creation Index ⓘ	-0.2	-0.3	-0	-0.3	-0.4	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	20.1	21.4	20.4	29.7	24.3	24.2	24
Sales YoY Gr.	-	6.7%	-4.8%	45.5%	-18.2%	-0.4%	-
Adj EPS ⓘ	0.2	0.7	2.3	1.8	2.4	1	-2.3
YoY Gr.	-	213%	223.6%	-24%	36.2%	-60.6%	-
BVPS (₹) ⓘ	10.4	11.1	13.5	47.4	50	47.6	47.6
Adj Net Profit ⓘ	0.2	0.7	2.3	2.5	3.4	1.3	-3
Cash Flow from Ops. ⓘ	9	4.6	4.4	7.8	11	-14.9	-
Debt/CF from Ops. ⓘ	3.6	7.4	8.8	2.5	1	-0.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	3.8%	5.9%	-0.4%
Adj EPS ⓘ	NA	32.8%	-25.9%	-60.6%
BVPSⓘ	NA	35.5%	52.4%	-4.7%
Share Price	-	-	-31.9%	-14%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	2.2	6.7	18.9	6.2	5	2	-4.9
Op. Profit Mgn % ⓘ	39.1	35.7	43.6	31.7	28	26.7	NAN
Net Profit Mgn % ⓘ	1.1	3.3	11.3	8.3	13.8	5.5	-13.4
Debt to Equity ⓘ	3.1	3.1	2.9	0.3	0.2	0.2	-
Working Cap Days ⓘ	0	269	383	501	825	868	0
Cash Conv. Cycle ⓘ	0	89	78	39	73	43	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 5.86%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Nidan Laboratories And Healthcare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-2.3	-
TTM Sales (₹ Cr.)	24.2	-
BVPS (₹.) ⓘ	47.6	-
Reserves (₹ Cr.) ⓘ	52	-
P/BV ⓘ	0.60	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	40
Equity (₹ Cr.)	13.9
Face Value (₹)	10
Industry PE ⓘ	40.5

Management X-Ray of Nidan Labs. & Health:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Nidan Labs. & Health

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Nidan Labs. & Health

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	20.06	21.41	20.38	29.66	24.27	24.18
Operating Expenses ⓘ	12.22	13.77	11.49	20.25	17.46	17.73
Manufacturing Costs	2.13	2.42	1.16	5.77	4.92	6.04
Material Costs	1.72	2.55	2.21	3.09	1.09	1.01
Employee Cost	2.35	2.77	2.85	3.59	4.88	4.46
Other Costs ⓘ	6.02	6.04	5.27	7.80	6.57	6.22
Operating Profit ⓘ	7.84	7.64	8.89	9.41	6.80	6.44
Operating Profit Margin (%)	39.1%	35.7%	43.6%	31.7%	28.0%	26.7%
Other Income ⓘ	0.37	0.01	1.06	0.40	3.33	2.75
Interest ⓘ	4.75	3.74	3.46	2.66	2.22	2.18
Depreciation ⓘ	3.24	3.19	3.18	2.63	3.10	2.87
Exceptional Items ⓘ	0	0	0	0	0	-6.51
Profit Before Tax ⓘ	0.22	0.71	3.30	4.52	4.81	-2.37
Tax ⓘ	0	0	1	1.86	1.27	0.86
Profit After Tax	0.22	0.71	2.30	2.66	3.54	-3.23
PAT Margin (%)	1.1%	3.3%	11.3%	9.0%	14.6%	-13.4%
Adjusted EPS (₹)	0.2	0.7	2.3	1.9	2.6	-2.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	10.31	11.03	13.33	65.90	69.44	66.21
Share Capital ⓘ	9.90	9.90	9.90	13.90	13.90	13.90
Reserves ⓘ	0.41	1.13	3.43	52	55.54	52.31
Minority Interest	0	0	0	0	0	0
Debt	32.17	34.35	22.91	18.13	9.66	11.66
Long Term Debt	32.17	34.35	14.16	9.42	4.77	4.29
Short Term Debt	0	0	8.76	8.71	4.89	7.37
Trade Payables	0.55	-0.18	1.29	1.15	0.21	0.73
Others Liabilities ⓘ	-0.22	-0.24	15.96	2.85	4.61	3.14
Total Liabilities ⓘ	42.81	44.96	53.49	88.03	83.92	81.73
Fixed Assets
Gross Block	55.36	55.37	58.36	59.74	60.65	57.67
Accumulated Depreciation	32.08	35.26	38.45	39.28	39.26	39.72
Net Fixed Assetsⓘ	23.28	20.10	19.92	20.46	21.39	17.95
CWIP ⓘ	0	0	0.23	3.81	0	0.04
Investmentsⓘ	0.53	0.53	0.27	0	0	0
Inventories	0.08	0.09	0.11	0.22	0.37	0.30
Trade Receivables	5.61	5.43	5.43	5.36	6.03	0.52
Cash Equivalents	4.34	7.39	7.30	8.10	8.42	2.85
Others Assetsⓘ	8.97	11.42	20.24	50.07	47.72	60.07
Total Assets ⓘ	42.81	44.96	53.49	88.03	83.92	81.73

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	8.95	4.62	4.35	7.83	10.97	-14.93
PBT ⓘ	0.22	0.71	3.30	4.52	4.81	-2.37
Adjustment ⓘ	7.99	6.93	6.55	4.54	2.04	9.19
Changes in Working Capital ⓘ	0.74	-3.03	-5.51	-0.07	4.15	-18.95
Tax Paid ⓘ	0	0	0	-1.16	-0.03	-2.80
Cash Flow From Investing Activity ⓘ	1	-0.01	-3.22	-35.74	-0.29	9.84
Capex	1	-0.01	-3.22	-6.48	0.05	-0.64
Net Investments	0	0	0	0	0	0
Others ⓘ	0	0	0	-29.26	-0.34	10.48
Cash Flow From Financing Activityⓘ	-5.81	-1.56	-1.22	28.72	-10.37	-0.49
Net Proceeds from Shares ⓘ	0	0	0	49.91	0	0
Net Proceeds from Borrowing ⓘ	-1.06	2.18	2.15	-18.75	-8.36	1.49
Interest Paid ⓘ	-4.75	-3.74	-3.36	-2.44	-2	-1.97
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0
Net Cash Flow ⓘ	4.14	3.05	-0.10	0.80	0.32	-5.57

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	2.17	6.7	18.9	6.72	5.23	-4.77
ROCE (%)	11.71	10.15	13.98	10.52	8.5	-0.24
Asset Turnover Ratio	0.47	0.49	0.41	0.42	0.28	0.29
PAT to CFO Conversion(x)	40.68	6.51	1.89	2.94	3.1	N/A
Working Capital Days
Receivable Days	102	94	97	66	86	49
Inventory Days	1	1	2	2	4	5
Payable Days	116	26	91	144	227	169

Nidan Laboratories And Healthcare Ltd Stock News

Nidan Laboratories And Healthcare Ltd FAQs

What is the share price of Nidan Labs. & Health?

Company share prices are keep on changing according to the market conditions. The closing price of Nidan Labs. & Health on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Nidan Labs. & Health?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Nidan Labs. & Health stood at ₹40.03.

What is the P/E ratio of Nidan Labs. & Health?

The latest P/E ratio of Nidan Labs. & Health as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Nidan Labs. & Health?

The latest P/B ratio of Nidan Labs. & Health as of 01-Jan-1970 05:30 is 0.60.

What is the 52-week high and low of Nidan Labs. & Health?

The 52-week high of Nidan Labs. & Health is ₹0.00 and the 52-week low is ₹0.00.

What is the TTM revenue of Nidan Labs. & Health?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nidan Labs. & Health is ₹24.18 ( Cr.) .

About Nidan Laboratories And Healthcare Ltd

Nidan Laboratories and Healthcare was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 5, 2000 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, the name of the company was changed from “Abhi Diagnostic Imagings Private Limited” to “Nidan Laboratoris And Healthcare Private Limited” under the Companies Act, 2013 pursuant to a special resolution passed by its shareholders at the EGM held on February 26, 2021 and had obtained fresh certificate of incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, the company was converted into a public limited company and the name of the company was changed to ‘Nidan Laboratories And Healthcare Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021.

The company was established as a proprietary Firm in 1994 by its Promoter- Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The business was carried out under sole proprietorship, which was later taken over by the company in 2000. From the year 2000, he expanded the diagnostic’s business by setting up various centre’s within the Northern District of Mumbai and Pune and Southern District of Pune.

Business area of the company

The company offers diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.